Format

Send to

Choose Destination
Crit Care. 2016 Jun 22;20(1):136. doi: 10.1186/s13054-016-1320-7.

Antibiotic strategies in the era of multidrug resistance.

Author information

1
Infectious Disease Section, Louisiana State University School of Medicine, New Orleans, LA, 70112, USA.
2
Réanimation Médicale, Groupe Hospitalier Pitié-Salpêtrière, 75013, Paris, France.
3
Department of Microbiology, Leeds Teaching Hospitals NHS Trust and University of Leeds, Leeds, LS1 3EX, UK.
4
Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium. jlvincent@intensive.org.

Abstract

The rapid emergence and dissemination of antibiotic-resistant microorganisms in ICUs worldwide threaten adequate antibiotic coverage of infected patients in this environment. The causes of this problem are multifactorial, but the core issues are clear: the emergence of antibiotic resistance is highly correlated with selective pressure resulting from inappropriate use of these drugs. Because a significant increase in mortality is observed when antibiotic therapy is delayed in infected ICU patients, initial therapy should be broad enough to cover all likely pathogens. Receipt of unnecessary prolonged broad-spectrum antibiotics, however, should be avoided. Local microbiologic data are extremely important to predict the type of resistance that may be present for specific causative bacteria, as is prior antibiotic exposure, and antibiotic choices should thus be made at an individual patient level.

PMID:
27329228
PMCID:
PMC4916531
DOI:
10.1186/s13054-016-1320-7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center